| Document Type
|
:
|
BL
|
| Record Number
|
:
|
1003851
|
| Doc. No
|
:
|
b758221
|
| Title & Author
|
:
|
Therapeutic strategies in dementia /\ edited by C.W. Ritchie [and others].
|
| Publication Statement
|
:
|
Oxford :: Clinical Pub.,, 2007.
|
| Page. NO
|
:
|
1 online resource (ix, 362 pages) :: illustrations
|
| ISBN
|
:
|
1280751215
|
|
|
:
|
: 1846925606
|
|
|
:
|
: 6610751218
|
|
|
:
|
: 9781280751219
|
|
|
:
|
: 9781846925603
|
|
|
:
|
: 9786610751211
|
|
|
:
|
190439258X
|
|
|
:
|
9781904392583
|
| Bibliographies/Indexes
|
:
|
Includes bibliographical references and index.
|
| Contents
|
:
|
Cover -- Contents -- Contributors -- Foreword -- Preface -- Section 1: Current pharmacological approaches in Dementia -- Chapter 1: Cholinesterase inhibitors: synthesis of meta-analysis/randomized controlled trials -- Chapter 2: Cholinesterase inhibitors: long-term studies -- Chapter 3: Cholinesterase inhibitors: head-to-head studies -- Chapter 4: Ginkgo biloba -- Chapter 5: Memantine -- Chapter 6: Anti-oxidant drugs -- Chapter 7: Pharmacoeconomic studies -- Section II: Biological Developments and Future Therapies -- Chapter 8: Disease-modifying therapeutic strategies for Alzheimer's disease: targeting the APP/Aß pathway -- Chapter 9: Anti-inflammatory drugs -- Chapter 10:Nicotine and amyloid-ß -- Chapter 11: Butyrylcholinesterase -- Chapter 12: Sex hormones in the treatment of Alzheimer's disease -- Chapter 13: Allosteric sensitization of brain nACh receptors as a treatment strategy in Alzheimer's dementia -- Chapter 14: The utility of biomarkers in the diagnosis and monitoring of Alzheimer's disease -- Section 3: Management of non-cognitive issues in dementia -- Chapter 15: Non-pharmacological interventions for BPSD -- Chapter 16: Pharmacological interventions for BPSD -- Chapter 17: Management of affective disorders in dementia -- Chapter 18: Management of vascular and other risks -- Chapter 19: Social management of dementia for patients and carers -- Section 4: Treatment of non-Alzheimer's disease cognitive impairment -- Chapter 20: Vascular dementia -- Chapter 21: Fronto-temporal dementia -- Chapter 22: Lewy body disease -- Chapter 23: Mild cognitive impairment -- Chapter 24: Delirium -- Abbreviations -- Index -- Last Page.
|
| Abstract
|
:
|
Widely acknowledged as one of the most challenging aspects of dealing with an ageing population, the increasing prevalence of cognitive decline in the elderly presents the clinician with a variety of complex therapeutic problems. Alzheimer's disease and other dementias vary in their onset and progression, as do patients in their responsiveness to treatment. Social management is as important as the choice of therapeutic agent, and implementing effective and sympathetic treatment requires care and sensitivity as well as a sound knowledge of currently available options. In this important new work, leading experts review the therapeutic agents currently available and assess their effectiveness. Also included is an update on recent and on-going clinical trials, the prospects for new therapeutic targets and the development of new biomarkers that will aid recognition of disease and earlier intervention.
|
| Subject
|
:
|
Alzheimer's disease-- Treatment.
|
| Subject
|
:
|
Dementia-- Treatment.
|
| Subject
|
:
|
Alzheimer Disease-- drug therapy.
|
| Subject
|
:
|
Central Nervous System Agents-- therapeutic use.
|
| Subject
|
:
|
Dementia-- therapy.
|
| Subject
|
:
|
Alzheimer's disease-- Treatment.
|
| Subject
|
:
|
Dementia-- Treatment.
|
| Subject
|
:
|
HEALTH FITNESS-- Diseases-- Alzheimer's Dementia.
|
| Subject
|
:
|
MEDICAL-- Neurology.
|
| Dewey Classification
|
:
|
616.8/3106
|
| LC Classification
|
:
|
RC521.T44 2007eb
|
| NLM classification
|
:
|
2007 A-515
|
|
|
:
|
WT 155T398 2007
|
| Added Entry
|
:
|
Ritchie, C. W., (Craig W.)
|